Personalized Medicine

Papers
(The median citation count of Personalized Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
The Integration of Personalized Medicine Into Health Systems: Progress and a Path Forward56
Expanded Carrier Screening in Flanders (Belgium): An Online Survey on the Perspectives of Nonpregnant Reproductive-Aged Women26
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness18
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension16
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls15
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis14
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients12
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population11
Pharmacogenomics education in China and the United States: advancing personalized medicine10
Prevalence of Protective Haplotypes of the SLCO1B1 Gene for Statin Transport in Mexican Populations9
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease9
Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer8
Association between IL-6, miRNA-146a, MALAT1 genetic polymorphisms and risk of rheumatoid arthritis8
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites8
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?7
Welcome to the 19th Volume of Personalized Medicine7
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation7
Omics Technologies in Personalized Combination Therapy for Cardiovascular Diseases: Challenges and Opportunities7
Personalized approach in arrhythmology by genetic-based data: a case report7
The effect of RNLS gene polymorphisms on preeclampsia susceptibility: a meta-analysis study7
miR-938 rs2505901 T>C Polymorphism Increases Hirschsprung Disease Risk: A Case–Control Study of Chinese Children7
The Frequency of Major CYP2C19 Genetic Polymorphisms in Women of Asian, Native Hawaiian and Pacific Islander Subgroups6
Precision medicine activities and opportunities for shaping maternal and neonatal health in Qatar6
Role of precision nutrition in improving military performance6
Identification of novel variants of XPA and POLH/XPV genes in xeroderma pigmentosum patients in Vietnam5
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries5
Development of Competency-based Online Genomic Medicine Training (COGENT)5
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine5
Developing New Frameworks to Value Genomic Information: Accounting for Complexity5
Looking Back Over 2023 and Welcome to the 21 st Issue of Personalized Medicine5
Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head5
A Personalized Approach to Pancreatic Ductal Adenocarcinoma and its Application in Surgical Practice5
Pharmacogenomic Considerations for Repurposing of Dexamethasone as a Potential Drug Against SARS-CoV-2 Infection5
Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device5
Sino-European Science and Technology Collaboration on Personalized Medicine: Overview, Trends and Future Perspectives4
The Use of Molecular Biomarker Tests: An Interview Study with Healthcare Providers about a Molecular Biomarker Test for Prostate Cancer4
Cloud-based Digital Healthcare Development for Precision Medical Hospital Information System4
Low Rate of Complications in Nipple-Sparing Mastectomy for Patients with BRCA1 and BRCA2 Mutation4
SKA3 , negatively regulated by miR-128-3p , promotes the progression of non-small-cell lung cancer4
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK4
Identification of Dpyd Variants and Estimation of Uracil and Dihydrouracil in A Healthy Indian Population4
Genomics and the early diagnosis of lung cancer4
A Real-World Analysis of Tyrosine Receptor Kinase Inhibitor-Related Toxicities in Cancer Treatment4
A GRIN3A Polymorphism may be Associated with Glucocorticoid-Induced Symptomatic Osteonecrosis in Children with Acute Lymphoblastic Leukemia4
Diagnostic Utility of the 23-gene Expression Profile Test for an Atypical Intradermal Melanocytic Proliferation4
HEcoPerMed, Personalized Medicine from a Health Economic Perspective: Lessons Learned and Potential Opportunities Ahead4
Clinical Significance of Serum miR-101-3p Expression in Patients with Neonatal Sepsis4
Recent Advances in Personalized Cancer Immunotherapy with Immune Checkpoint Inhibitors, T Cells and Vaccines4
Association of miR-21 gene polymorphisms with cognitive function in patients with systemic lupus erythematosus4
Preliminary Radiogenomic Study of Hepatitis B Virus-Related Hepatocellular Carcinoma: Associations between MRI Features and Mutations3
Impact of MIR137HG  rs7554283 on susceptibility to high-altitude pulmonary edema in the Chinese population3
Genetic and non-genetic factors influencing the therapeutic response of valproic acid in pediatric epileptic patients3
Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations3
Pharmacogenomics of Lipid-Lowering Agents: the Impact on Efficacy and Safety3
How people undergoing genomic sequencing interpret and react to varied secondary findings with limited actionability3
Anna Karenina Principle in Personalized Treatment of Bladder Cancer According to Oncogram: Which Drug for which Patient?3
The United States 2020 Census Data: Implications for Precision Medicine and the Research Landscape3
The correlation between the polymorphism of lysolecithin acyltransferase (MBOAT7) rs641738 and liver fibrosis3
Cost–effectiveness of Genetic-Based Screening Strategies for Maturity-Onset Diabetes of the Young3
Corrigendum3
Clinician Perspectives on Communication and Implementation Challenges in Precision Oncology3
Global harmonization in advanced therapeutics: balancing innovation, safety, and access3
Development of a computer-based tool to obtain a family health history in Vietnam3
The Role of miR-101 in Esophageal and Gastric Cancer2
Challenges and Opportunities in Building a Health Economic Framework for Personalized Medicine in Oncology2
Helping patients understand multi-cancer early detection tests: a scoping review2
Personalized Medicine in Nepal: Current Scenario and Challenges2
A novel TGFβR2 splice variant in patient with aortic aneurysm and family history for aortic dissection: a case report2
Intelligent Health System for the Investigation of Consenting COVID-19 Patients and Precision Medicine2
CYP2D6 Genotyping and the Clinical Impact on Outcomes in Breast Cancer Tamoxifen-Treated Patients2
Vancomycin individual dosing regimens via Bayesian simulation: a 5-year retrospective study on preterm and term neonates2
Biomarker Testing in Patients Diagnosed With Advanced/Metastatic Medullary Thyroid Cancer in the USA2
Head-to-head comparison of tyrosine kinase inhibitors in renal cell carcinoma using patient-derived cell culture2
Sars-Cov-2 Variant Identification Using a Genome Tiling Array and Genotyping Probes2
Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer2
Pharmacogenetic Testing in Pediatric Neurology: a Pragmatic Study Evaluating Clinician and Patient Perceptions2
The Roots of (in)Equity in Precision Medicine: Gaps in the Discourse2
Pharmacogenomic analysis and clinical annotation of 635 patients2
An International Genomics Health Workforce Education Priorities Assessment1
Long Noncoding RNA Polymorphisms and Hepatocellular Carcinoma and Pancreatic Cancer Risk1
Medical geneticists, genetic diseases and services in Brazil in the age of personalized medicine1
Healthcare Professionals’ Knowledge, Attitudes and Future Expectations Towards Personalized Medicine1
Evaluating the Quality of the Economic Evidence in Colorectal Cancer Genomics Studies1
Aminoglycosides’ Dosage in Hematological Malignancies and Febrile Neutropenia: Extended Interval or Conventional Dosage?1
Development and evaluation of an exome sequencing training course for medical interpreters1
LncRNA Polymorphisms and Lung Cancer Risk1
Deliberations About Clinical Pharmacogenetic Testing in Pediatric Oncology1
Prioritizing Pharmacogenomics Implementation Initiatives: A Survey of Healthcare Professionals1
Assessment of ADRB1 polymorphism in patients with acute coronary syndrome treated with ticagrelor and aspirin1
Content Highlights of the Year: a Look Over 2022 at Personalized Medicine1
Efficacy of trastuzumab deruxtecan in treating HER2-low breast cancer leptomeningeal metastasis: a case report1
Association between PRNCR1 , PAX8AS1 , MEG3 , and PTENP1 gene polymorphisms 1
Successful Management of Delayed-Onset Adenosine Deaminase Deficiency with Novel Mutation1
HER2 in Gastric Adenocarcinoma: Where Do we Stand Today?1
Maternal and Placental ANRIL Polymorphisms and Preeclampsia Susceptibility1
Personalized Therapy: Can it Tame the COVID-19 Monster?1
Risk of Polymyxin B-Induced acute Kidney Injury with a Non Adjusted Dose Versus Adjusted Dose Based on Renal Function1
Introduction of a single-nucleotide variant, rs16851030, into the ADORA1 gene increased cellular susceptibility to hypoxia1
State-of-the-art knowledge on the regulation of advanced therapy medicinal products1
Pathology-Supported Genetic Testing Presents Opportunities for Improved Disability Outcomes in Multiple Sclerosis1
Five genes identified as prognostic markers for colorectal cancer through the integration of genome-wide association study and expression quantitative trait loci data1
Preferences for pharmacogenomic testing in polypharmacy patients: a discrete choice experiment1
A Sociogenomic Paradigm to Replace the Racial Paradigm1
The effect of genetic polymorphisms of AKT1 on PE susceptibility: a case-control study and insilico analysis1
0.11770987510681